Windtree Therapeutics, a biotech and BNB treasury firm, saw its shares crash 77% on Wednesday. The sharp drop followed a notice from the Nasdaq Stock Market, which informed the company it would be delisted for failing to meet listing requirements. In a filing to the US Securities and Exchange Commission (SEC) on Tuesday, Windtree confirmed […]